Stream of funding spurs advances in human health:
Arizona State University Biodesign Institute researchers have received three significant new grants, advancing knowledge of digestive proteins in the human gut, toxic exposure to fungi during childhood and long-term vaccine effectiveness. Continue reading
Author Archive: AZBio
reimagine Health Research Symposium Focuses on Big Data’s Role in Transforming Care
Fifth Annual Symposium welcomed experts, who shared how big data and precision medicine are set to markedly improve clinical outcomesContinue reading
Game Changer: The Arizona Health Innovation Trust Fund
Established in 2022, the Arizona Health Innovation Trust Fund (AHIT) is designed to help Arizona become home to a top-ten life science sector by helping to bridge the “valley of death.” During the 2023 legislative session, our elected leaders have the opportunity to make the investment that will capitalize the AHIT. Continue reading
First-of-its-kind instrument officially ushers in new era of X-ray science
“This marks the beginning of a new era of science with compact accelerator-based X‑ray sources,” said Robert Kaindl, who directs ASU’s Compact X-ray Free Electron Laser (CXFEL) Labs at the Biodesign Institute and is a professor in the Department of Physics. “The CXLS provides hard X-ray pulses with high flux, stability and ultrashort durations, in a very compact footprint. This way, matter can be resolved at its fundamental scales in space and time, enabling new discoveries across many fields — from next-generation materials for computing and information science, to renewable energy, biomolecular dynamics, drug discovery and human health.”Continue reading
Exact Sciences and PGA Tour Champions Extend Partnership Through 2027
Tucson, Ariz. (February 1, 2023) – The PGA TOUR Champions, the Tucson Conquistadores, the First Tee Tucson, and Exact Sciences, the maker of Cologuard®, announced today that the Madison, Wisconsin-based company will now be the presenting sponsor of the Cologuard Classic. The announcement also extends Cologuard’s title sponsorship through the 2027 season. The 2023 Cologuard Classic by Exact Sciences will take place at the Omni Tucson National Resort from February 27th through March 5th and will have a $2.2 million purse, with $330,000 to the winner.Continue reading
AZAdvances Talent Program Internship Opportunities
A component of the AZAdvances Talent Program, AZAdvances internships are designed to support Arizona students as they explore career paths in health and life sciences. Internships are created in partnership with AZBio member organizations and are supported though grants and donations to the Opportunity Through Entrepreneurship Foundation’s benefiting the AZAdvances initiative.Continue reading
A Natural Non-invasive Neuro-technology Improves Sleep and Wellbeing in Randomized, Controlled Clinical Trial
The Post-COVID world has an increased population suffering from sleep issues, and good sleep is the basis to good health. An insomnia intervention which is natural and non-invasive can be an important aspect to achieve improved health in a post-COVID world.Continue reading
Arizona’s Opportunity to Drive Health Innovation Forward Faster
In 2022, Arizona established the Arizona Health Innovation Trust Fund as a vehicle to drive the creation of health innovations that can improve quality of life for people of Arizona and increase opportunities for the high quality jobs Arizona Health Innovators create. The FY2023 appropriation was $100,000 to allow the initial set up of the fund. In 2023, two bills at the Arizona Legislature (HB2253 and SB1084) propose a $200 million dollar one-time investment into the Arizona Health Innovation Trust Fund.Continue reading
C-Path’s TRxA Announces its First Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects
Launched in 2022, the Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. TRxA is now accepting applications for its 2023 funding cycle.Continue reading